CRISPR Therapeutics co-founder uncloaks an off-the-shelf cell therapy startup with $87M and a lot of fanfare

When Chad Cowan was recruited to Harvard University 20 years ago to work on human embryonic stem cells, he was inspired by the idea that …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

CRISPR Ther­a­peu­tics co-founder un­cloaks an off-the-shelf cell ther­a­py start­up with $87M and a lot of fan­fare